Does pPARgamma activation attenuate T-lymphocyte-dependent inflammation of adipose tissue and development of insulin resistance in obese mice?
Together the present study demonstrates a close connection between PPARgamma-mediated anti-inflammation in AT and systemic improvement of glucose metabolism identifying T-lymphocytes as one cellular mediator of PPARgamma´s action.
Our analysis shows that OPCAB improves the early outcome and that octogenarians can lead event-free lives after cardiac surgery.